Abstract:Calcium ions (Ca2+) play a complex role in orchestrating diverse cellular processes, including cell death and survival. To trigger signaling cascades, intracellular Ca2+ is shuffled between the cytoplasm and the major Ca2+ stores, the endoplasmic reticulum (ER), the mitochondria, and the lysosomes. A key role in the control of Ca2+ signals is attributed to the inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs), the main Ca2+-release channels in the ER. IP3Rs can transfer Ca2+ to the mitochondria, thereby not only stimulating core metabolic pathways but also increasing apoptosis sensitivity and inhibiting basal autophagy. On the other hand, IP3-induced Ca2+ release enhances autophagy flux by providing cytosolic Ca2+ required to execute autophagy upon various cellular stresses, including nutrient starvation, chemical mechanistic target of rapamycin inhibition, or drug treatment. Similarly, IP3Rs are able to amplify Ca2+ signals from the lysosomes and, therefore, impact autophagic flux in response to lysosomal channels activation. Furthermore, indirect modulation of Ca2+ release through IP3Rs may also be achieved by controlling the sarco/endoplasmic reticulum Ca2+ ATPases Ca2+ pumps of the ER. Considering the complex role of autophagy in cancer development and progression as well as in response to anticancer therapies, it becomes clear that it is important to fully understand the role of the IP3R and its cellular context in this disease. In cancer cells addicted to ER-mitochondrial Ca2+ fueling, IP3R inhibition leads to cancer cell death via mechanisms involving enhanced autophagy or mitotic catastrophe. Moreover, IP3Rs are the targets of several oncogenes and tumor suppressors and the functional loss of these genes, as occurring in many cancer types, can result in modified Ca2+ transport to the mitochondria and in modulation of the level of autophagic flux. Similarly, IP3R-mediated upregulation of autophagy can protect some cancer cells against natural killer cells-induced killing. The involvement of IP3Rs in the regulation of both autophagy and apoptosis, therefore, directly impact cancer cell biology and contribute to the molecular basis of tumor pathology.

Regulation of Beclin 1-Mediated Autophagy by Oncogenic Tyrosine Kinases

AMPK Regulates Autophagy by Phosphorylating BECN1 at Threonine 388.

Beclin-1: autophagic regulator and therapeutic target in cancer.

Regulation of Beclin 1 in Autophagy.

Autophagy-Related Beclin 1 and Head and Neck Cancers

Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy

Beclin 1 Phosphorylation - at the Center of Autophagy Regulation

The Role of Beclin 1-Dependent Autophagy in Cancer

Post-translational modifications of Beclin 1 provide multiple strategies for autophagy regulation

Regulation of the Tumor-Suppressor BECLIN 1 by Distinct Ubiquitination Cascades

The Function of Bcl-2/Beclin-1 Complex in Autophagy Regulation

Acetylation of Beclin 1 Inhibits Autophagosome Maturation and Promotes Tumour Growth

BECLIN1: Protein Structure, Function and Regulation

Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy.

Knockdown of Beclin-1 Impairs Epithelial-Mesenchymal Transition of Colon Cancer Cells.

IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer

Role and Regulation of Autophagy in Cancer

A Non-canonical MEK/ERK Signaling Pathway Regulates Autophagy Via Regulating Beclin 1*

Beclin 1 Bridges Autophagy, Apoptosis and Differentiation

Distinct Regulation of Autophagic Activity by Atg14L and Rubicon Associated with Beclin 1–Phosphatidylinositol-3-kinase Complex